Sarnat-Kucharczyk Monika, Pojda-Wilczek Dorota, Mrukwa-Kominek Ewa, Kos-Kudła Beata, Janik Małgorzata A, Janik Paweł
Department of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
Kornel Gibinski University Clinical Centre, 40-514 Katowice, Poland.
Cancers (Basel). 2025 May 1;17(9):1542. doi: 10.3390/cancers17091542.
BACKGROUND/OBJECTIVES: This prospective study evaluates the relationship between the ganglion cell-inner plexiform layer (GCIPL), retinal nerve fiber layer (RNFL), and photopic negative response (PhNR) in patients with newly diagnosed pituitary macroadenomas over 12 months.
A total of 40 patients (80 eyes) were included, divided into a treatment group of 27 patients (54 eyes), receiving pharmacological and/or surgical intervention, and an observation group of 13 patients (26 eyes), with non-functional pituitary adenomas (NFPAs) that did not require treatment.
Key findings indicate a significant improvement in best corrected visual acuity (BCVA) after 12 months in the treatment group ( = 0.02) and a significant reduction in RNFL thickness in multiple quadrants ( < 0.01). Moreover, PhNR amplitude and W-ratio significantly increased in the treatment group ( < 0.0001). In the observation group, only GCIPL Inferior ( = 0.0470) and PhNR W-ratio ( = 0.0015) showed significant differences. Between-group comparisons showed significant differences in RNFL Nasal quadrant at baseline ( = 0.0017) and after 12 months ( = 0.0150). PhNR amplitude and W-ratio also differed significantly between groups at 12 months ( = 0.0012 and = 0.0016, respectively). Correlations between OCT and ERG parameters were weak at baseline and diminished over time.
These findings suggest that GCIPL, RNFL, and PhNR analyses may be useful for monitoring disease progression and guiding treatment decisions in patients with pituitary macroadenomas.
背景/目的:本前瞻性研究评估新诊断的垂体大腺瘤患者在12个月内神经节细胞-内网状层(GCIPL)、视网膜神经纤维层(RNFL)和明视负反应(PhNR)之间的关系。
共纳入40例患者(80只眼),分为治疗组27例(54只眼),接受药物和/或手术干预;观察组13例(26只眼),为无需治疗的无功能性垂体腺瘤(NFPA)。
主要发现表明,治疗组在12个月后最佳矫正视力(BCVA)有显著改善(P = 0.02),多个象限的RNFL厚度显著降低(P < 0.01)。此外,治疗组的PhNR振幅和W比值显著增加(P < 0.0001)。在观察组中,仅GCIPL下部(P = 0.0470)和PhNR W比值(P = 0.0015)显示出显著差异。组间比较显示,基线时RNFL鼻侧象限有显著差异(P = 0.0017),12个月后也有显著差异(P = 0.0150)。12个月时,PhNR振幅和W比值在组间也有显著差异(分别为P = 0.0012和P = 0.0016)。OCT和ERG参数之间的相关性在基线时较弱,且随时间减弱。
这些发现表明,GCIPL、RNFL和PhNR分析可能有助于监测垂体大腺瘤患者的疾病进展并指导治疗决策。